Childhood onset diabetes posttransplant in a girl with TCF2 mutation

Pediatr Diabetes. 2012 Sep;13(6):e35-9. doi: 10.1111/j.1399-5448.2011.00842.x. Epub 2012 Jan 20.

Abstract

Heterozygous mutations of TCF2 (transcription factor 2) have been associated with maturity onset diabetes of the young, renal malformations, hyperuricemia, and occasionally internal genital malformations in female. We report a female patient with bilateral renal hypodysplasia and de novo heterozygous TCF2 gene mutation. At the age of 9 yr, she developed transient ketoacidosis immediately posttransplant, temporarily requiring insulin. During glucocorticoid tapering, impaired glucose tolerance persisted and overt insulin-dependent diabetes mellitus developed 1 yr later. Pathogenic factors which might have played a role in the acceleration of diabetes were (i) switch from cyclosporine to tacrolimus, (ii) weight excess, and (iii) cytomegalovirus infection. TCF2 analysis might, therefore, be of interest in patients with congenital abnormalities of the kidney and the urinary tract in order to improve posttransplant management in terms of steroid and tacrolimus exposure.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Abnormalities, Multiple / surgery
  • Child
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / etiology*
  • Diabetes Mellitus, Type 2 / genetics
  • Female
  • Hepatocyte Nuclear Factor 1-beta / genetics*
  • Humans
  • Kidney / abnormalities
  • Kidney / surgery
  • Kidney Transplantation / adverse effects*
  • Mutation* / physiology
  • Transplantation Conditioning / adverse effects
  • Urinary Tract / abnormalities
  • Urinary Tract / surgery
  • Urogenital Abnormalities / complications
  • Urogenital Abnormalities / genetics
  • Urogenital Abnormalities / surgery

Substances

  • HNF1B protein, human
  • Hepatocyte Nuclear Factor 1-beta